Follow Up Urged on All Drugs from Meningitis Pharmacy

Report this content

More than 1,200 clinics, doctors, and hospitals around the country are contacting patients they injected with drugs made by the New England Compounding Center (NECC) because federal regulators are concerned the products may present a risk of infection.

The Washington Post reports that the follow-up request from the Food and Drug Administration (FDA) is for patients who received other NECC injectable drugs, not the steroid (methylprednisolone acetate) linked to the deadly fungal meningitis outbreak. The FDA’s website lists 1,279 health care providers that bought drugs from NECC, although the agency says the list was provided by the company and may be incomplete.

Last week the FDA broadened its warning to health-care providers about all NECC’s injectable drugs because of new cases of infections linked to two other products. The number of people now at a risk of infection from these drugs is unknown, say officials, although more than 14,000 people received tainted steroid injections made by NECC.

So far, 24 people have died and 317 have been sickened in 17 states in the ongoing meningitis outbreak, according to the Centers for Disease Control.

If you or a loved one has been harmed by a dangerous drug, contact Sokolove Law today for a free legal consultation and to find out if a dangerous drug lawyer may be able to help you.

Tags: